El-Shal Laila Moustafa, El-Star Alyaa A Abd, Azmy Abeer M, Elnegris Heba M
Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Department of Histology and Cell Biology, Faculty of Medicine, Badr University in Cairo, Cairo, Egypt.
Ultrastruct Pathol. 2022 Jan 2;46(1):18-36. doi: 10.1080/01913123.2021.2007194. Epub 2022 Jan 3.
Obesity is a major universal health issue linked to a majority of illness.
To evaluate the histological and biochemical changes occurred in the duodenal mucosa of high fat diet HFD and orlistat fed rats and to assess the possible protective role of N-acetyl cysteine NAC supplementation.
Sixty male albino rats weighing 180-200 g were classified randomly into control group I and three experimental groups (HFD group II, HFD + orlistat group III, and HFD + orlistat + NAC group IV). All experimental groups received HFD alone/and treatment for 6 weeks. Group III received orlistat (32 mg/kg/day) before meals and group IV received the same regimen as group III in addition to NAC (230 mg/kg/day) after meals. After completion of the experiment, duodenal sections were processed for histological examination, oxidative stress parameters, and semiqualitative real time PCR for proinflammatory mediators TNFα and IL6 evaluation. Also, plasma lipid parameters were assessed and morphometric duodenal results were analyzed statistically.
By histological examination of HFD and (HFD + orlistat) groups, we found severe to moderate duodenal structural disturbances, increased goblet cells, collagen fibers, and BAX and iNOS immunostaining. By Biochemical examination, both groups showed increased proinflammatory markers level (TNFα and IL6) with decreased all antioxidant parameters and increased MDA. Moreover, NAC treatment in group IV significantly reduced all structural changes, levels of proinflammatory mediators and increased all antioxidant parameter levels and decreased MDA.
All findings elucidated that NAC could be accounted to be a useful drug for protection of duodenal mucosa of HFD and orlistat treated animals.
肥胖是一个与大多数疾病相关的主要全球性健康问题。
评估高脂饮食(HFD)和服用奥利司他的大鼠十二指肠黏膜发生的组织学和生化变化,并评估补充N-乙酰半胱氨酸(NAC)可能的保护作用。
将60只体重180 - 200克的雄性白化大鼠随机分为对照组I和三个实验组(HFD组II、HFD + 奥利司他组III、HFD + 奥利司他 + NAC组IV)。所有实验组单独接受HFD/或进行6周治疗。III组在饭前服用奥利司他(32毫克/千克/天),IV组除与III组接受相同方案外,饭后还接受NAC(230毫克/千克/天)。实验结束后,对十二指肠切片进行组织学检查、氧化应激参数检测以及用于评估促炎介质TNFα和IL6的半定量实时PCR检测。此外,评估血浆脂质参数,并对十二指肠形态学结果进行统计学分析。
通过对HFD组和(HFD + 奥利司他)组的组织学检查,我们发现十二指肠结构出现严重至中度紊乱,杯状细胞、胶原纤维以及BAX和iNOS免疫染色增加。生化检查显示,两组促炎标志物水平(TNFα和IL6)均升高,所有抗氧化参数降低,MDA升高。此外,IV组的NAC治疗显著减少了所有结构变化、促炎介质水平,提高了所有抗氧化参数水平并降低了MDA。
所有研究结果表明,NAC可被认为是一种保护HFD和接受奥利司他治疗动物十二指肠黏膜的有效药物。